Dupilumab use in allergic contact dermatitis - 13/12/18
Doi : 10.1016/j.jaad.2018.07.043
Brian C. Machler, MD a, Calvin T. Sung, BS b, Evan Darwin, BS c, Sharon E. Jacob, MD d, ⁎ 
a Center for Dermatology, Florham Park, New Jersey
b School of Medicine, University of California, Riverside, Riverside, California
c Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
d Department of Dermatology, Loma Linda University, Loma Linda, California
∗Correspondence to: Sharon E. Jacob, MD, Dermatology, Loma Linda University Department of Dermatology, 11370 Anderson St, Ste 2600, Loma Linda, CA 92354DermatologyLoma Linda University Department of Dermatology11370 Anderson St, Ste 2600Loma LindaCA92354
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the authors. |
© 2018
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 80 - N° 1
P. 280 - janvier 2019 Retour au numéro
Article précédent
- Survey analysis on the management of moderately dysplastic nevi among academic dermatologists across the United States
- Kristen M. Tessiatore, Hyunji Choi, Ambuj Kumar, Nishit S. Patel
- Growth in the cost of biologics in Medicare beneficiaries, 2013 to 2016
- Partik Singh, Jonathan I. Silverberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?